Increase program success with precision dosing intelligence
Plan and execute drug optimization strategies starting in Phase I.
Leverage model-informed precision dosing (MIPD), Bayesian forecasting, and machine learning to test multiple dose ranges for easy identification of target dose levels and intervals.
Maximize drug efficacy and safety for participants
Avoid sub-therapeutic and supra-therapeutic dosing by targeting specific drug exposures or biomarker ranges.
InsightRX Nova accounts for individual concentration levels, lab results, and patient demographics — helping to sidestep risks associated with maximum tolerated dose (MTD)-based regimens.
Boost patient enrollment and retention in trials
High variability and adverse drug reactions can drive patient dropout, costing organizers up to 30% of enrollees and significant financial impact.
Precision dosing supports therapeutic target achievement and uses real-time drug response predictions to identify vulnerable patients early, which can help reduce adverse events and improve retention.
